WSC 2025 | Misconceptions surrounding the use of adipose-derived mesenchymal stem cell therapy for stroke
Exuperio Díez-Tejedor, MD, PhD, La Paz University Hospital, Madrid, Spain, discusses the misconceptions surrounding the use of adipose-derived mesenchymal stem cell therapy for the treatment of stroke. Dr Díez-Tejedor highlights that the primary mechanism of these cells is to promote the production of new neural cells and repair brain damage, rather than replacing damaged cells. This interview took place at the 17th World Stroke Congress (WSC) in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
More people consider it necessary to use neural stem cells only. They have doubts related to mesenchymal stem cells and more doubts related to adipose cells because adipose cells are not specially related to the nervous system. But the question is it’s not necessary to replace neural cells with mesenchymal stem cells or another type of cell. It’s not necessary for replacement. The mechanism of stem cells in general is to promote the production of new neural cells in the brain and repair brain damage...
More people consider it necessary to use neural stem cells only. They have doubts related to mesenchymal stem cells and more doubts related to adipose cells because adipose cells are not specially related to the nervous system. But the question is it’s not necessary to replace neural cells with mesenchymal stem cells or another type of cell. It’s not necessary for replacement. The mechanism of stem cells in general is to promote the production of new neural cells in the brain and repair brain damage. This question is not well understood by all people.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
